Advertisement

Ads Placeholder
Loading...

Ind-Swift Laboratories Limited

INDSWFTLAB.NS•NSE
Healthcare
Drug Manufacturers - Specialty & Generic
₹138.85
₹0.68(0.49%)
Indian Market opens in 55h 21m

Ind-Swift Laboratories Limited (INDSWFTLAB.NS) Stock Overview

Explore Ind-Swift Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.3B
P/E Ratio4.11
EPS (TTM)$34.49
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$118.74
3 Months$75.61
1 Year Target$118.74

INDSWFTLAB.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ind-Swift Laboratories Limited (INDSWFTLAB.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $118.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4.11 and a market capitalization of 11.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.49%
5-Day Change
1.72%
1-Month Change
10.006%
3-Month Change
51.67%
6-Month Change
42.79%
Year-to-Date (YTD) Change
53.44%
1-Year Change
51.35%
3-Year Change
140.64%
5-Year Change
84.40%
All-Time (Max) Change
574.03%

Contact Information

https://www.indswiftlabs.com
91 17 2273 0503
Shivalik Enclave, Manimajra, NaN, 160101

Company Facts

470 Employees
IPO DateJul 1, 2002
CountryIN
Actively Trading

Frequently Asked Questions